Table 1 Summary of case reports of four patients with Parkinson's disease switched to LCE 200
Case 1 | Case 2 | Case 3 | Case 4 | |
|---|---|---|---|---|
Sex | Male | Male | Male | Male |
Age (years) | 48 | 69 | 72 | 65 |
Duration of Parkinson's disease (years) | 4 | 14 | 8 | 13 |
Hoehn & Yahr stage | 2 | OFF 3/ON 2.5 | 2 | 2.5 |
Duration of levodopa therapy (years) | 2 | 12 | 5 | 8 |
Motor complications | Wearing-off | Dyskinesia, wearing-off, delayed ON time, morning akinesia | None | Dyskinesia, wearing-off |
Symptom benefit? | Equal | Yes | Yes | Yes |
Convenience benefit? | Yes | Yes | Not stated | Not stated |
AEs associated with switching to LCE 200? | No | No | No | No |